Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GOUT

From hyperuricaemia to gout: what are the missing links?

A new epidemiological study suggests that only half of patients with hyperuricaemia will go on to develop gout. If ‘the glass is only half-full’, then is hyperuricaemia the most important risk factor for the development of gout?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Clinical manifestations of chronic hyperuricaemia.

References

  1. Pascart, T. & Lioté, F. Gout: state of the art after a decade of developments. Rheumatology https://doi.org/10.1093/rheumatology/key002 (2018).

    Article  Google Scholar 

  2. Shiozawa, A. et al. Serum uric acid and the risk of incident and recurrent gout: a systematic review. J. Rheumatol. 44, 338–396 (2017).

    Article  CAS  Google Scholar 

  3. Yamanaka, H., Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 30, 1018–1029 (2011).

    Article  PubMed  CAS  Google Scholar 

  4. Bardin, T. & Richette, P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 15, 123 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dalbeth, N. et al. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann. Rheum. Dis. 77, 1048–1052 (2018).

    Article  PubMed  Google Scholar 

  6. Bardin, T. Hyperuricemia starts at 360 micromoles (6 mg/dL). Joint Bone Spine 82, 141–143 (2015).

    Article  PubMed  CAS  Google Scholar 

  7. Dalbeth, N. & Stamp, L. Hyperuricaemia and gout: time for a new staging system? Ann. Rheum. Dis. 73, 1598–1600 (2014).

    Article  PubMed  Google Scholar 

  8. Kumagai, T. et al. Time to target uric acid to retard CKD progression. Clin. Exp. Nephrol. 21, 182–192 (2017).

    Article  PubMed  CAS  Google Scholar 

  9. Chhana, A., Lee, G. & Dalbeth, N. Factors influencing the crystallization of monosodium urate: a systematic literature review. BMC Musculoskelet. Disord. 16, 296 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Chatfield, S. M. et al. Monosodium urate crystals generate nuclease-resistant neutrophil extracellular traps via a distinct molecular pathway. J. Immunol. 200, 1802–1816 (2018).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frédéric Lioté.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lioté, F., Pascart, T. From hyperuricaemia to gout: what are the missing links?. Nat Rev Rheumatol 14, 448–449 (2018). https://doi.org/10.1038/s41584-018-0040-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-018-0040-6

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing